Intensive induction regimens after deferring initial therapy for mantle cell lymphoma are not associated with improved survival

Author:

Shanmugasundaram Krithika1ORCID,Goyal Subir2,Switchenko Jeffery2,Calzada Oscar3,Churnetski Michael C.3,Kolla Bhaskar4,Bachanova Veronika4,Gerson James N.5,Barta Stefan K.5,Gordon Max J.6,Danilov Alexey V.6,Grover Natalie S.7,Mathews Stephanie7,Burkart Madelyn8,Karmali Reem8,Sawalha Yazeed9ORCID,Hill Brian T.9,Ghosh Nilanjan10,Park Steven I.10,Epperla Narendranath1112,Bond David A.11,Badar Talha12,Blum Kristie A.3,Hamadani Mehdi13,Fenske Timothy S.13,Malecek Mary14,Kahl Brad S.14,Martin Peter15,Guo Jin16,Flowers Christopher R.16,Cohen Jonathon B.3

Affiliation:

1. National Institutes of Health National Cancer Institute Bethesda MD US

2. Winship Cancer Institute, Biostatistics and Bioinformatics Emory University Atlanta GA US

3. Department of Hematology and Medical Oncology Winship Cancer Institute Emory University Hospital Atlanta GA US

4. Division of Hematology Oncology and Transplantation University of Minnesota Minneapolis MN US

5. Hematology and Oncology Hospital of the University of Pennsylvania Philadelphia PA US

6. Knight Cancer Institute Oregon Health and Science University Portland OR US

7. Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill NC US

8. Division of Hematology Northwestern University Chicago IL US

9. Department of Hematology and Medical Oncology Taussig Cancer Institute Cleveland Clinic Foundation Cleveland OH US

10. Levine Cancer Institute Charlotte NC US

11. Division of Hematology The Ohio State University Cancer Center Columbus OH US

12. Mayo Clinic Jacksonville FL US

13. Division of Hematology and Oncology Medical College of Wisconsin Milwaukee WI US

14. Siteman Cancer Center Washington University St. Louis MO US

15. Weill Cornell Medicine New York NY US

16. Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston TX US

Funder

National Cancer Institute

Publisher

Wiley

Subject

Hematology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3